Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$177.8 - $270.58 $374,091 - $569,300
-2,104 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$121.0 - $257.67 $254,584 - $542,137
2,104 New
2,104 $447,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Q Pula Trading Management LP Portfolio

Follow Q Pula Trading Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Q Pula Trading Management LP with notifications on news.